Data-independent acquisition-based quantitative proteomic analysis of m.3243A>G MELAS reveals novel potential

Xueli Chang1, Zhaoxu Yin1, Wei Zhang1

  • 1Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

Medicine
|October 18, 2022
PubMed

Insights

Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS) pathogenesis involves altered protein expression, particularly in oxidative stress and mitochondrial ribosome proteins. This proteomic study reveals key molecular players in MELAS.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • The exact mechanisms driving mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS) remain unclear.
  • The common m.3243A>G mutation impacts proteins with unknown functions, necessitating further investigation.

Purpose of the Study:

  • To conduct a quantitative proteomic analysis of skeletal muscle from MELAS patients to identify differentially expressed proteins.
  • To elucidate the molecular pathogenesis of MELAS, particularly concerning the m.3243A>G mutation.

Main Methods:

  • Quantitative proteomic analysis using nanospray liquid chromatography-mass spectrometry (LC-MS) with data-independent acquisition (DIA).
  • Recruitment of 10 MELAS patients and 10 age/gender-matched controls.
  • Bioinformatics analysis including Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis.

Main Results:

  • Identified 128 differentially expressed proteins (68 down-regulated, 60 up-regulated) between MELAS patients and controls.
  • Key proteins involved in oxidative stress (e.g., HSPB1, HMOX1, G6PD) were identified.
  • Enrichment analysis highlighted pathways related to phagosomes, ribosomes, and peroxisome proliferator-activated receptors (PPARs).

Conclusions:

  • Oxidative stress imbalance, autophagosome activation, and abnormal mitochondrial ribosome protein metabolism are implicated in m.3243A>G MELAS pathogenesis.
  • Proteomic and bioinformatics approaches offer comprehensive insights into MELAS molecular networks.
  • Further research into these identified proteins and pathways could reveal therapeutic targets.